Get the Stockscreener App
32.26
0.67%
0.2149
Virtus Lifesci Biotech Clinical Trials Etf stock is traded at $32.26, with a volume of 21,211.
It is up +0.67% in the last 24 hours and up +18.19% over the past month.
See More
Previous Close:
$32.04
Open:
$32
24h Volume:
21,211
Relative Volume:
1.42
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+5.53%
1M Performance:
+18.19%
6M Performance:
+68.98%
1Y Performance:
+13.47%
1-Day Range:
$31.95
$32.35
1-Week Range:
$30.93
$32.50
52-Week Range:
$13.42
$32.50
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
Name
Virtus Lifesci Biotech Clinical Trials Etf
Sector
Industry
Phone
-
Address
-
Compare BBC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBC
Virtus Lifesci Biotech Clinical Trials Etf
|
32.26 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.42 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
682.06 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
685.23 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
254.99 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
629.07 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Latest News
Biotech ETF (BBC) Hits New 52-Week High - MSN
Virtus LifeSci Biotech Clinical Trials ETF (BBC) stock price, news, quote and history - Yahoo! Finance UK
Biotech ETFs Hovering Around a 52-Week: Here's Why - Nasdaq
Biotech ETFs Bounce Back in 2025: Here's Why - sharewise.com
Can Virtus LifeSci Biotech Clinical Trials stock deliver strong annual returns2025 Pullback Review & Fast Entry Momentum Alerts - nchmf.gov.vn
Discipline and Rules-Based Execution in BBC Response - news.stocktradersdaily.com
Trade War or Not, Specific Industry ETFs Are in Sweet Spots - TradingView
What MACD trends signal for Virtus LifeSci Biotech Clinical Trials stockWeekly Trade Review & Weekly Top Gainers Trade List - newser.com
Will Virtus LifeSci Biotech Clinical Trials stock return to pre crash levelsMarket Movers & Proven Capital Preservation Methods - newser.com
The Zacks Analyst Blog Highlights BWET, GOEX, SLVP, LIT and BBC - sharewise.com
Best-Performing ETFs of Last Week - sharewise.com
Canadian Equities Shine: ETFs to Capture the Momentum - The Globe and Mail
2 High Risk ETFs That Aren’t Leveraged, Inverse, or Single-Stock - Investing.com
XBI: Surprise Exit Of A Tough Regulator At The FDA (NYSEARCA:XBI) - Seeking Alpha
(BBC) Technical Data - news.stocktradersdaily.com
How to Take Advantage of moves in (BBC) - news.stocktradersdaily.com
(BBC) Trading Report - news.stocktradersdaily.com
(BBC) Trading Signals - news.stocktradersdaily.com
Learn to Evaluate (BBC) using the Charts - news.stocktradersdaily.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On - Benzinga
Tech Rally Boosted Wall Street Last Week: Winning ETFs in Focus - TradingView
6 Best-Performing ETFs of Last Week - TradingView
Wall Street Week Ahead - Seeking Alpha
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
5 Top ETFs of Last Week - Yahoo Finance
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - Nasdaq
Pharma Stocks Look Cheap. Here's One Way to Invest. - Nasdaq
Virtus LifeSci Biotech Clinical Trials ETF (BBC) Stock Trends and Sentiment 2025 - MarketBeat
Long Term Trading Analysis for (BBC) - news.stocktradersdaily.com
The 5 Best Biotech ETFs of 2024 - ETF.com
Last Week, Virtus LifeSci Biotech Clinical Trials ETF Climbed 10%. Why? - CMC Markets
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
ALPS’ Biotech ETF SBIO Week's Top Performer - ETF Trends
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - FA Mag
Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal - ETF Trends
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Zacks Investment Research
Biotech ETFs Are Making a Comeback - ETF Trends
Biotech ETF Tops in June: 5 Stocks That Outperform - Zacks Investment Research
Biotech ETFs Strengthen as Bristol Myers Squibb Buys Turning Point - ETF Trends
How to Pick a Biotech ETF - Investment U
Positioning for Biotech Bounceback - ETF Trends
Make Biotech Cash Considerations With SBIO - ETF Trends
Some Biotech Stocks Are Now Cheap - ETF Trends
Biotech M&A Could Finally Perk Up in 2022 - ETF Trends
Biotech ETFs That Outperformed Last Week - Yahoo Finance
Biotech Stocks Have Colds, but They Can Heal - ETF Trends
Size Up SBIO Ahead of Biotech Rebound - ETF Trends
Finding Synergy With SPY - ETF.com
Biotech ETFs Surge on Biogen's Alzheimer Drug Approval - Nasdaq
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Financials Data
There is no financial data for Virtus Lifesci Biotech Clinical Trials Etf (BBC). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.09%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):